Liv Vernstrøm
6PUBLICATIONS
8CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Mar 14, 2025
Colchicine mitigates arterial stiffness in high-risk patients with type 2 diabetes: a randomized placebo-controlled trial.Jonathan M Baier, Kristian L Funck, Liv Vernstrøm
|Jul 30, 2024
Effects of semaglutide, empagliflozin and their combination on renal diffusion-weighted MRI and total kidney volume in patients with type 2 diabetes: a post hoc analysis from a 32 week randomised trial.Liv Vernstrøm, Søren Gullaksen, Steffen S Sørensen
|May 13, 2024
Correction: Separate and combined effects of semaglutide and empagliflozin on kidney oxygenation and perfusion in people with type 2 diabetes: a randomised trial.Søren Gullaksen, Liv Vernstrøm, Steffen S Sørensen
|Jan 19, 2024
Separate and combined effects of empagliflozin and semaglutide on vascular function: A 32-week randomized trial.Liv Vernstrøm, Søren Gullaksen, Steffen S Sørensen
|Feb 06, 2023
Separate and combined effects of semaglutide and empagliflozin on kidney oxygenation and perfusion in people with type 2 diabetes: a randomised trial.Søren Gullaksen, Liv Vernstrøm, Steffen S Sørensen
|Apr 22, 2019
Differential vascular effects of aspirin in people with Type 2 diabetes without cardiovascular disease and matched controls without diabetes.L Vernstrøm, E Laugesen, E L Grove
Pageof 1
